|
Tatva Chintan Pharma Chem Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1779.08 Cr.
|
P/BV
|
2.41
|
Book Value (Rs.)
|
315.32
|
|
52 Week High/Low (Rs.)
|
1222/621
|
FV/ML
|
10/1
|
P/E(X)
|
311.45
|
|
Bookclosure
|
20/09/2024
|
EPS (Rs.)
|
2.44
|
Div Yield (%)
|
0.13
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 2.44 | 13.26 | 20.52 | 44.59 | 26.02 |
| Diluted EPS (Rs.) | 2.44 | 13.26 | 20.52 | 44.59 | 26.02 |
| Cash EPS (Rs.) | 14.27 | 23.92 | 24.83 | 46.95 | 29.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 315.84 | 315.10 | 232.25 | 213.44 | 82.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 315.84 | 315.10 | 232.25 | 213.44 | 82.62 |
| Revenue From Operations / Share (Rs.) | 163.61 | 168.22 | 191.12 | 195.64 | 149.52 |
| PBDIT / Share (Rs.) | 15.62 | 32.36 | 29.92 | 52.84 | 35.66 |
| PBIT / Share (Rs.) | 3.79 | 21.42 | 25.61 | 49.16 | 32.31 |
| PBT / Share (Rs.) | 3.24 | 18.63 | 20.20 | 46.98 | 30.22 |
| Net Profit / Share (Rs.) | 2.44 | 12.98 | 20.52 | 43.25 | 26.02 |
| NP After MI And SOA / Share (Rs.) | 2.44 | 12.98 | 20.52 | 43.25 | 26.02 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 9.54 | 19.23 | 15.65 | 27.01 | 23.84 |
| PBIT Margin (%) | 2.31 | 12.73 | 13.40 | 25.12 | 21.60 |
| PBT Margin (%) | 1.98 | 11.07 | 10.57 | 24.01 | 20.20 |
| Net Profit Margin (%) | 1.49 | 7.71 | 10.73 | 22.10 | 17.39 |
| NP After MI And SOA Margin (%) | 1.49 | 7.71 | 10.73 | 22.10 | 17.39 |
| Return on Networth / Equity (%) | 0.77 | 4.11 | 8.83 | 20.26 | 31.48 |
| Return on Capital Employeed (%) | 1.19 | 6.77 | 10.91 | 22.37 | 32.98 |
| Return On Assets (%) | 0.68 | 3.70 | 6.01 | 14.56 | 16.60 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.02 | 0.16 |
| Total Debt / Equity (X) | 0.04 | 0.01 | 0.33 | 0.25 | 0.45 |
| Asset Turnover Ratio (%) | 0.46 | 0.49 | 0.59 | 0.88 | 1.04 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.76 | 3.74 | 1.33 | 2.54 | 1.56 |
| Quick Ratio (X) | 1.37 | 1.82 | 0.63 | 1.55 | 0.95 |
| Inventory Turnover Ratio (X) | 1.21 | 1.13 | 1.30 | 2.19 | 2.29 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 15.41 | 9.74 | 0.00 | 7.68 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 8.35 | 8.05 | 0.00 | 6.81 |
| Earning Retention Ratio (%) | 0.00 | 84.59 | 90.26 | 0.00 | 92.32 |
| Cash Earning Retention Ratio (%) | 0.00 | 91.65 | 91.95 | 0.00 | 93.19 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 28.32 | 11.59 | 7.89 | 24.24 | 17.03 |
| Interest Coverage Ratio (Post Tax) (%) | 5.43 | 5.65 | 6.84 | 20.84 | 13.42 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1610.49 | 2501.26 | 3820.18 | 5057.97 | 0.00 |
| EV / Net Operating Revenue (X) | 4.21 | 6.36 | 9.02 | 11.66 | 0.00 |
| EV / EBITDA (X) | 44.09 | 33.04 | 57.60 | 43.18 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 4.15 | 6.42 | 8.72 | 11.80 | 0.00 |
| Retention Ratios (%) | 0.00 | 84.58 | 90.25 | 0.00 | 92.31 |
| Price / BV (X) | 2.15 | 3.43 | 7.18 | 10.81 | 0.00 |
| Price / Net Operating Revenue (X) | 4.15 | 6.42 | 8.72 | 11.80 | 0.00 |
| EarningsYield | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
